Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The study was conducted as an open label, balanced, randomized, two-treatment, two-period,
two-sequence, single-dose, crossover bioavailability study comparing Ramipril capsules 10 mg
of OHM Laboratories Inc., USA with ALTACE® (ramipril) capsule 10 mg manufactured by King
Pharmaceuticals Inc., Bristol, TN 37620, USA in healthy, adult, male, human subjects under
fasting condition.